Aehr (AEHR) CEO Erickson Gayn Sells 40,000 Shares (~$5.23M)

What Happened

• Erickson Gayn, President, CEO and a director of Aehr Test Systems (AEHR), sold a total of 40,000 shares on August 12, 2026 in two dispositions. He sold 1,548 shares at $132.27 each (reported value $204,750) and 38,452 shares at $130.79 each (reported value $5,028,968), for a combined proceeds of approximately $5,233,718. These were sales (S) reported as open-market or private sales.

Key Details

• Transaction date: 2026-08-12; Form 4 filed: 2026-08-13 (timely; within the usual two-business-day reporting window).
• Lot 1: 1,548 shares @ $132.27 — $204,750 (reported).
• Lot 2: 38,452 shares @ $130.79 — $5,028,968 (reported).
• Total sold: 40,000 shares for ~$5,233,718.
• Shares owned after transaction: not specified in the provided excerpt of the filing.
• Footnote: The filing notes that the amount reported includes shares subject to unvested restricted stock units and unvested restricted shares (i.e., reported holdings may count some unvested awards).
• Transaction code: S = Sale. No 10b5-1 plan, tax withholding, or late filing flag indicated in the provided details.

Context

• This filing documents insider sales, which are common and can reflect liquidity needs or portfolio management; they are not, by themselves, definitive signals about the company’s prospects. The footnote about unvested RSUs/restricted shares means the reported figures for holdings may include shares that have not yet vested.